Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in P...
FY 2025
Mar 31, 2026
Q4 2025
FY 2023
Jun 29, 2023
Q2 2023
FY 2019
Dec 31, 2019